drugset / Trial / NCT02365857
Intrathecal Dexmedetomidine With Bupivacaine for Spinal Anesthesia in Cesarean Section
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Controlled, Double blind study aiming to evaluate the analgesic potentials and side effect profile of different dose levels of Dexmedetomidine added to subarachnoid bupivacaine in full-term pregnant women undergoing elective cesarean section using spinal anesthesia. The investigators ultimate goal is to find out the least effective dose which will be associated with minimal or no side effects. The primary outcome will be the time to two sensory block segment regression.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-07
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Comparator | Dexmedetomidine | Other / unclassified | 10 ug | Intrathecal |
| Comparator | Dexmedetomidine | Other / unclassified | 15 ug | Intrathecal |
| Comparator | Bupivacaine | Other / unclassified | 12.5 mg | Intrathecal |
Indications
No indication recorded.